Key result
Vitamin D and catechin prevent diabetic cardiomyopathy progression in rats by reducing oxidative stress and fibrosis.
Why the study?
This study aimed to evaluate the cardioprotective effects of Vitamin D and Catechin against diabetic cardiomyopathy in a rat model, specifically focusing on attenuating cardiac fibrosis.
Does Vitamin D and Catechin improve diabetic cardiomyopathy in a rat model?
Population
Fifty male Sprague-Dawley rats
Comparison
Control vs DCM vs Vit D vs Cat vs combination treatment
Design
Animal study
Authors
Loading...
Should not yet change practice; leaves open efficacy of Vitamin D and catechin in human diabetic cardiomyopathy.
Does Vitamin D and Catechin improve diabetic cardiomyopathy in a rat model?
Vitamin D and Catechin demonstrate cardioprotective effects against diabetic cardiomyopathy in a rat model by targeting the TGF-β1/SMAD pathway and MMP-9 activity.
Elnaggar et al. (2026) studied Diabetic cardiomyopathy (n=50). Vitamin D and Catechin vs. Control and untreated DCM groups was evaluated on Heart function, glucose levels, cardiac injury biomarkers, oxidative stress markers, and cardiac fibrosis. Vitamin D and Catechin treatment prevented diabetic cardiomyopathy progression in rats by lowering blood sugar, reducing oxidative stress, and inhibiting fibrosis and MMP-9 activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: